Related Experiment Video
Updated: Feb 6, 2026
05:18
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
1.5K
New treatment modalities for obesity.
A Grandone1, A Di Sessa1, G R Umano1
1Department of Woman, Child and of General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy; Via L. De Crecchio, 4, 80138, Naples, Italy.
Summary
Pediatric obesity treatments are evolving, with new drugs and bariatric surgery showing modest effects. Research into novel approaches like adipose tissue browning is ongoing for better childhood obesity management.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Pharmacology
Background:
- Childhood obesity is a significant pediatric health challenge requiring multidisciplinary management.
- Current treatment options (behavioral, dietary, pharmacological, surgical) have limited efficacy.
- Active research is exploring novel therapeutic strategies for pediatric obesity.
Purpose of the Study:
- To review current knowledge on emerging treatment options for pediatric obesity.
- To summarize findings on pharmacological and surgical interventions.
- To explore novel approaches like adipose tissue browning.
Main Methods:
- Literature review of recent clinical trials and scientific research.
- Analysis of pharmacological agents studied for pediatric obesity.
- Evaluation of bariatric surgery and novel therapeutic targets.
Main Results:
- Several drugs (Metformin, GLP-1 agonists, etc.) show modest weight loss effects in children.
- Bariatric surgery is a promising option for severely obese adolescents.
- Adipose tissue browning is a potential future strategy, but human evidence is lacking.
Conclusions:
- Pharmacological and surgical options offer modest benefits for pediatric obesity.
- Long-term studies are crucial to establish the definitive role of these treatments.
- Further research is needed to validate novel approaches like adipose tissue browning in humans.
Related Concept Videos
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:15Sensory Modalities
3.9K
Sensation typically is the process by which the sensory receptors and sense organs detect stimuli from the internal and external environment and transmit this information to the central nervous system for processing.
General senses refer to the broad category of sensory information detected by receptors in the body and can be further grouped into somatic and visceral senses. Somatic sensations include touch, pressure, temperature, and pain and are essential for navigating our environment and...
General senses refer to the broad category of sensory information detected by receptors in the body and can be further grouped into somatic and visceral senses. Somatic sensations include touch, pressure, temperature, and pain and are essential for navigating our environment and...
3.9K
01:21Drug Dosing: Obese Patients
268
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
268
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
286
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
286
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
191
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
191
01:27Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K